Kalkinemedia
MMay 12, 2020
Mesoblast Securities in Trading HaltA global leader in developing innovative allogeneic cellular medicines, Mesoblast Limited (ASX:MSB) has requested its securities to be placed in a trading halt on ASX, pending it releasing an announcement.
Moreover, the securities are scheduled to begin normal trading on Wednesday, 13 May 2020 or when the official statement is let out to the market.
The Company has recently declared the dosing of its first patients in the 300-patient placebo-controlled, randomised Phase 2/3 trial in the US for Mesoblast’s remestemcel-L. The medicine is being investigated in COVID-19 infected patients that have ARDS (moderate to severe) and are on ventilator support.
Related: Mesoblast Commences Enrollment for Phase 2/3 Trial of Remestemcel-L for COVID-19 Treatment
With a strong and extensive global intellectual property (IP) portfolio, MSB has protection extending through to at least 2040 in all major markets and the same is expected to offer substantial commercial advantages to the Company through the development of its product candidates for these conditions.
Stock Information
Source: ASX
Ann: Trading Halt, page-757
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.025(2.45%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.04 | 99.5¢ | $4.379M | 4.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 163238 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 19700 | 2 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |